K. Shi

发表

Artificial Neural Network Accurately Predicts Hepatitis B Surface Antigen Seroclearance

I. Hung, M. Yuen, D. Wong, 2014, PloS one.

AKI-CLIF-SOFA: a novel prognostic score for critically ill cirrhotic patients with acute kidney injury

Zhi Mao, M. Zheng, K. Shi, 2017, Aging.

Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection

Sven Van Poucke, M. Zheng, K. Shi, 2017, Journal of clinical and translational hepatology.

Title Artificial neural network accurately predicts hepatitis B surfaceantigen seroclearance

M. Yuen, D. Wong, J. Fung, 2014 .

The tumour necrosis factor‐α‐238A allele increases the risk of chronic HBV infection in European populations

M. Zheng, K. Shi, Y.‐C. Fan, 2012, Journal of viral hepatitis.

Tumor necrosis factor-alpha-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations.

M. Zheng, K. Shi, H. Pan, 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Tumour necrosis factor‐α‐857T allele reduces the risk of hepatitis B virus infection in an Asian population

M. Zheng, K. Shi, X-H Cai, 2012, Journal of viral hepatitis.

NAFL screening score: A basic score identifying ultrasound-diagnosed non-alcoholic fatty liver.

M. Zheng, K. Shi, Wen-Yue Liu, 2017, Clinica chimica acta; international journal of clinical chemistry.

The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target

M. Braddock, M. Zheng, K. Shi, 2014, Expert opinion on therapeutic targets.

Autophagy in ethanol-exposed liver disease

M. Braddock, M. Zheng, K. Shi, 2015, Expert review of gastroenterology & hepatology.

BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor.

K. Shi, Zhuo-lin Zou, Yong-Ping Chen, 2014, International journal of clinical and experimental pathology.

Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation

K. Shi, Xiangjian Chen, Zhuo Lin, 2015, Oncotarget.

Nonalcoholic Fatty Liver Disease

M. Braddock, M. Zheng, K. Shi, 2015, Medicine.

Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation

M. Zheng, K. Shi, Ji-Na Zheng, 2016, Oncotarget.

Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantation.

M. Braddock, M. Zheng, K. Shi, 2014, Gene.

A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma.

K. Shi, Xiao-dong Wang, Mengtao Zhou, 2017, Clinica chimica acta; international journal of clinical chemistry.

Combined AFP-CRUT with microvascular invasion accurately predicts mortality risk in patients with hepatocellular carcinoma following curative liver resection

M. Braddock, M. Zheng, K. Shi, 2015, Expert review of gastroenterology & hepatology.

Upper Limits of Normal for Serum Alanine Aminotransferase Levels in Chinese Han Population

M. Zheng, K. Shi, Wen-Yue Liu, 2012, PloS one.

Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

M. Zheng, K. Shi, Ji-Na Zheng, 2016, Medicine.

C-reactive protein-to-albumin ratio is a predictor of hepatitis B virus related decompensated cirrhosis: time-dependent receiver operating characteristics and decision curve analysis

M. Zheng, K. Shi, Yi-Jing Cai, 2017, European journal of gastroenterology & hepatology.

Association between a Lumican Promoter Polymorphism and High Myopia in the Chinese Population: A Meta-Analysis of Case-Control Studies

K. Shi, Kai-Fu Tang, Jianmin Wu, 2014, Ophthalmologica.

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.

K. Shi, Bin-Qiao Wang, Yong-Lin Wang, 2017 .

Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease

M. Braddock, M. Zheng, K. Shi, 2015, Oncotarget.

Is an elevated hemoglobin concentration a novel risk factor for metabolic syndrome in the Chinese population? a large-scale study

Sven Van Poucke, M. Zheng, K. Shi, 2014 .

Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study

M. Braddock, M. Zheng, K. Shi, 2016, BMJ Open.

A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis

M. Braddock, M. Zheng, K. Shi, 2015, Oncotarget.

Prognostic value of DNA repair based stratification of hepatocellular carcinoma

K. Shi, Mengtao Zhou, Li Ying, 2016, Scientific Reports.

Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries

M. Yuen, D. Wong, M. Zheng, 2014, Molecular Biology Reports.

Pharmacotherapy for Hepatic encephalopathy: view of Evidence-Based

K. Shi, Dan-Qin Sun, A. Wu, 2011 .

Interleukin-28B rs12979860C/T and rs8099917T/G contribute to spontaneous clearance of hepatitis C virus in Caucasians.

Y. Li, M. Zheng, K. Shi, 2013, Gene.

Reply to: Comments on “Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma”

K. Shi, Mengtao Zhou, P. Li, 2019, Bioscience reports.

Interleukin-28B polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis.

M. Zheng, K. Shi, Wen-Yue Liu, 2012, Gene.

A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.

M. Zheng, K. Shi, Yong-Ping Chen, 2010, Clinical therapeutics.

Meta‐analysis using individual participant data is the gold standard for diagnostic studies

M. Zheng, K. Shi, Yu-Chen Fan, 2011, Hepatology.

Methodological quality assessment for traditional Chinese medicine: CONSORT is better

M. Zheng, K. Shi, Yu-Chen Fan, 2011, Hepatology.

LPS pretreatment ameliorates D-galactosamine/lipopolysaccharide-induced acute liver failure in rat.

K. Shi, Liping Wang, Jin-zhong Dong, 2014, International journal of clinical and experimental pathology.

Serum alkaline phosphatase, a risk factor for non-alcoholic fatty liver, but only for women in their 30s and 40s: evidence from a large cohort study

M. Zheng, K. Shi, Wen-Yue Liu, 2017, Expert review of gastroenterology & hepatology.

Letter: there is something about the Neutrophil‐to‐Lymphocyte ratio (NLR)…—authors' reply

K. Shi, M-T Zhou, Y.-J. Cai, 2017, Alimentary pharmacology & therapeutics.

Relationship between IL‐10 gene −1082A/G and −592C/A polymorphisms and the risk of hepatitis C infection: a meta‐analysis

K. Shi, Kai-Fu Tang, J. Wu, 2013, Journal of viral hepatitis.

Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis

M. Braddock, M. Zheng, K. Shi, 2015, Oncotarget.

Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review

M. Braddock, M. Zheng, K. Shi, 2014, Expert review of gastroenterology & hepatology.

[Short-term results of telbivudine versus entecavir treatments in HBeAg-positive chronic hepatitis B patients in China].

K. Shi, H. Ren, Xiao-feng Shi, 2008, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute‐on‐chronic liver failure

K. Shi, Yi-Jing Cai, Y.‐P. Chen, 2017, Alimentary pharmacology & therapeutics.

Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis

M. Zheng, K. Shi, S. Van Poucke, 2017, Expert review of anti-infective therapy.

Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

K. Shi, Bin-Qiao Wang, Yong-Lin Wang, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Skin lesion in a critically ill man

M. Zheng, K. Shi, Yong-Ping Chen, 2015, BMJ : British Medical Journal.

A New Strategy for Treatment of Liver Fibrosis

M. Zheng, K. Shi, T. Yang, 2012, BioDrugs.

Dicer interacts with SIRT7 and regulates H3K18 deacetylation in response to DNA damaging agents

K. Shi, Kai-Fu Tang, Yunsheng Xu, 2015, Nucleic acids research.

Dicer interacts with SIRT7 and regulates H3K18 deacetylation in response to DNA damaging agents

K. Shi, Kai-Fu Tang, Yunsheng Xu, 2015, Nucleic acids research.

The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention

M. Braddock, M. Zheng, K. Shi, 2016, Expert review of gastroenterology & hepatology.

NRAL mediates cisplatin resistance in hepatocellular carcinoma via miR-340-5p/Nrf2 axis

K. Shi, Lili Wu, Liang Shi, 2018, Journal of Cell Communication and Signaling.

MicroRNA-581 promotes hepatitis B virus surface antigen expression by targeting Dicer and EDEM1.

K. Shi, Kai-Fu Tang, Yong-Ping Chen, 2014, Carcinogenesis.

Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells.

K. Shi, Jimin Gao, Kai-Fu Tang, 2014, Carcinogenesis.

Identification of circulating extracellular vesicle long RNAs as diagnostic biomarkers for patients with severe acute pancreatitis

K. Shi, Hui-ping Li, Qingfu Zhu, 2022, Clinical and translational medicine.

Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance

Ming-Hua Zheng, Lei Zhang, Zhuo Lin, 2015, Oncotarget.

Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma

K. Shi, Mengtao Zhou, Feng Wang, 2018, Bioscience reports.

A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma

K. Shi, Mengtao Zhou, Bi-cheng Chen, 2017, Journal of gastroenterology and hepatology.

A novel genomic-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.

K. Shi, Fubiao Ni, Zhuo Lin, 2020, Clinica chimica acta; international journal of clinical chemistry.

Development of a prognostic nomogram for cirrhotic patients with upper gastrointestinal bleeding

M. Braddock, M. Zheng, K. Shi, 2017, European journal of gastroenterology & hepatology.

Quick chronic liver failure-sequential organ failure assessment: an easy-to-use scoring model for predicting mortality risk in critically ill cirrhosis patients

M. Braddock, M. Zheng, K. Shi, 2017, European journal of gastroenterology & hepatology.

Systematic Review With Network Meta-Analysis

Martin Braddock, Ming-Hua Zheng, Yong-Ping Chen, 2015, Medicine.

Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine.

M. Zheng, K. Shi, H. Cai, 2013, Annals of hepatology.

Aquaporin, a kind of membrane channel protein, maybe a new promising therapeutic target for non-alcoholic fatty liver disease

M. Zheng, K. Shi, Li-xin Qiu, 2009 .

Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease

M. Braddock, M. Zheng, K. Shi, 2016, Expert opinion on therapeutic targets.

Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple‐treatments meta‐analysis

M. Zheng, K. Shi, Wen-Yue Liu, 2013, European journal of clinical investigation.

Association between a polymorphism in miR-34b/c and susceptibility to cancer--a meta-analysis.

K. Shi, Kai-Fu Tang, Zhuo Lin, 2014, Asian Pacific journal of cancer prevention : APJCP.

Association between a Polymorphism in miR-34 b / c and Susceptibility to Cancer-a Meta-analysis

K. Shi, Kai-Fu Tang, Zhuo Lin, 2014 .

Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma

K. Shi, Li-sha Ying, Jia-Jia Dong, 2019, Cancer Cell International.

Association Between Sex-Specific Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Chinese Adults

M. Braddock, M. Zheng, K. Shi, 2015, Medicine.

Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease

M. Braddock, M. Zheng, K. Shi, 2015, Medicine.

Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis

Zhi-rui Zhou, M. Braddock, M. Zheng, 2015, Oncotarget.

Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis

Martin Braddock, Ming-Hua Zheng, Gui-Qi Zhu, 2015, Medicine.

Usefulness of albumin‐bilirubin grade for evaluation of long‐term prognosis for hepatitis B‐related cirrhosis

M. Zheng, K. Shi, Yi-Jing Cai, 2017, Journal of viral hepatitis.

National incidence of autoimmune liver diseases and its relationship with the human development index

Sven Van Poucke, M. Zheng, K. Shi, 2016, Oncotarget.

Systematic review with network meta‐analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy

M. Braddock, M. Zheng, K. Shi, 2015, Alimentary pharmacology & therapeutics.

Clinical utility of acoustic radiation force impulse imaging for identification of malignant liver lesions: a meta-analysis

K. Shi, Li Ying, Xiao-Hua Lin, 2012, European Radiology.

Performance of Platelet Count/Spleen Diameter Ratio for Diagnosis of Esophageal Varices in Cirrhosis: A Meta-Analysis

K. Shi, Li Ying, Xiao-Hua Lin, 2012, Digestive Diseases and Sciences.

Conditional survival estimate of acute-on-chronic hepatitis B liver failure: A dynamic prediction based on a multicenter cohort

M. Zheng, K. Shi, Hai Li, 2015, Oncotarget.

LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer

K. Shi, Chenwei Pan, Kaili Luo, 2019, Journal of experimental & clinical cancer research : CR.

Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection

M. Braddock, M. Zheng, K. Shi, 2015, PloS one.

Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: A meta‐analysis of diagnostic accuracy

Li Ying, Kai-Fu Tang, Ke-Qing Shi, 2014, Journal of gastroenterology and hepatology.

Systematic review with network meta‐analysis: adjuvant therapy for resected biliary tract cancer

M. Braddock, M. Zheng, K. Shi, 2014, Alimentary pharmacology & therapeutics.

Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis

M. Zheng, K. Shi, Wen-Yue Liu, 2012, Molecular Biology Reports.

Remodeling the model for end‐stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injury

Sven Van Poucke, Ming-Hua Zheng, Ke-Qing Shi, 2017, Hepatology communications.

Classification and regression tree analysis of acute‐on‐chronic hepatitis B liver failure: Seeing the forest for the trees

M. Braddock, M. Zheng, K. Shi, 2017, Journal of viral hepatitis.

A model to predict 3‐month mortality risk of acute‐on‐chronic hepatitis B liver failure using artificial neural network

M. Zheng, K. Shi, Y.‐C. Fan, 2013, Journal of viral hepatitis.

Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study

M. Yuen, D. Wong, M. Zheng, 2014, Molecular Biology Reports.

Transient elastography: a meta‐analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease

M. Zheng, K. Shi, Wen-Yue Liu, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Risk stratification of spontaneous bacterial peritonitis in cirrhosis with ascites based on classification and regression tree analysis

M. Zheng, K. Shi, Yu-Chen Fan, 2011, Molecular Biology Reports.

A New Strategy for Treatment of Liver Fibrosis

M. Zheng, K. Shi, Tao Yang, 2013, BioDrugs.

Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer

M. Braddock, M. Zheng, K. Shi, 2015, Oncotarget.

Development and validation of a prognostic nomogram for acute‐on‐chronic hepatitis B liver failure

K. Shi, Yi-Jing Cai, Yong-Ping Chen, 2017, Journal of gastroenterology and hepatology.

A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure.

Yu-Chen Fan, Ming-Hua Zheng, Ke-Qing Shi, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.

K. Shi, P. Johnson, P. Lai, 2018, Clinica chimica acta; international journal of clinical chemistry.

Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study

M. Yuen, D. Wong, M. Zheng, 2014, Molecular Biology Reports.

Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target

M. Braddock, M. Zheng, K. Shi, 2015, Expert opinion on therapeutic targets.

Robust Acute Pancreatitis Identification and Diagnosis: RAPIDx.

Luke P. Lee, Fei Liu, K. Shi, 2023, ACS nano.

A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B

K. Shi, Yi-Jing Cai, Y.‐P. Chen, 2017, Journal of viral hepatitis.

Scoring model to predict outcome in critically ill cirrhotic patients with acute respiratory failure: comparison with MELD scoring models and CLIF-SOFA score

M. Zheng, K. Shi, Wen-Yue Liu, 2017, Expert review of gastroenterology & hepatology.

Clinical utility of endoscopic ultrasound elastography for identification of malignant pancreatic masses: A meta‐analysis

K. Shi, Kai-Fu Tang, Li Ying, 2013, Journal of gastroenterology and hepatology.

Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis

M. Zheng, K. Shi, Wen-Yue Liu, 2012, Molecular Biology Reports.

A MELD-based nomogram for predicting 3-month mortality of patients with acute-on-chronic hepatitis B liver failure.

K. Shi, Yi-Jing Cai, Zhuo Lin, 2017, Clinica chimica acta; international journal of clinical chemistry.

Risk stratification of spontaneous bacterial peritonitis in cirrhosis with ascites based on classification and regression tree analysis

M. Zheng, K. Shi, Yu-Chen Fan, 2012, Molecular Biology Reports.

Neutrophil-lymphocyte ratio predicts hospital-acquired bacterial infections in decompensated cirrhosis.

K. Shi, Yi-Jing Cai, Yong-Ping Chen, 2017, Clinica chimica acta; international journal of clinical chemistry.

Establishment and Validation of ALPH-Q Score to Predict Mortality Risk in Patients With Acute-on-Chronic Hepatitis B Liver Failure

M. Zheng, K. Shi, Yu-Chen Fan, 2015, Medicine.

Ten‐year follow‐up analysis of chronic hepatitis C patients after getting sustained virological response to pegylated interferon‐α and ribavirin therapy

Y. Huang, K. Shi, Yuanping Zhou, 2016, Journal of viral hepatitis.